Ernexa Therapeutics Inc (ERNA)

Jun 14, 2026

ERNA Q3 2023 Earnings: Pre-Revenue Biotech Reports Wider Loss as Stock DeclinesSubscription Growth Report - newsline.com

Jun 14, 2026

Jun 12, 2026

Ernexa Therapeutics (ERNA) Drops Over 6%: Key Support Levels in FocusFibonacci Fan - newsline.com

Jun 12, 2026

Jun 12, 2026

Number of shareholders of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView

Jun 12, 2026

Jun 11, 2026

Ernexa Therapeutics stock climbs on breakthrough preclinical data - MSN

Jun 11, 2026

Jun 11, 2026

ERNA Stock Surged 60% Today – Here’s Why Retail Is Buzzing About Ernexa’s Ovarian Cancer Trial Results - Stocktwits

Jun 11, 2026

Jun 10, 2026

ERNA stock shoots up 140% in a month: Here's what you should know - MSN

Jun 10, 2026

Jun 09, 2026

Ernexa highlights ERNA-101's potential to improve ovarian cancer treatment with scalable, off-the-shelf cell therapy. - Pluang

Jun 09, 2026

Jun 09, 2026

Ernexa Therapeutics Highlights Innovative Cell Therapy Approaches for Ovarian Cancer in Virtual Investor KOL Connect Segment - Quiver Quantitative

Jun 09, 2026

Jun 09, 2026

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer - Yahoo Finance

Jun 09, 2026

Jun 03, 2026

ERNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Jun 03, 2026

Jun 03, 2026

ERNA Q3 2023 Earnings: Pre-Revenue Biotech Reports Wider Loss, Shares Tumble 12%EBITDA Analysis - newsline.com

Jun 03, 2026

May 29, 2026

Ernexa Therapeutics Warrants (ERNAW) Slide Over 20% as Key Support NearsPositive Gamma - The Legal Advocate

May 29, 2026

May 29, 2026

Ernexa Therapeutics Warrants Drop 21.76%: Warrants Plunge Below Key Support LevelMomentum ETF - The Legal Advocate

May 29, 2026

May 29, 2026

Ernexa Therapeutics (ERNA) Faces Sharp Sell-Off, Testing Key Support at $10.20Elliott Wave Count - newsline.com

May 29, 2026

May 28, 2026

Ernexa Therapeutics (ERNA) Surges 4.31%: Key Levels and Technical OutlookFloat Adjusted Cap - The Legal Advocate

May 28, 2026

May 28, 2026

Ernexa Therapeutics Inc. (ERNA) Q3 2023 Earnings: Negative EPS as Company Advances PipelinePre-Earnings Drift - The Legal Advocate

May 28, 2026

May 28, 2026

Number of shareholders of Ernexa Therapeutics Inc. – NASDAQ:ERNA - TradingView

May 28, 2026

May 27, 2026

Ernexa Therapeutics Warrants (ERNAW) Slide Marginally to $0.15, Testing Key Support ZoneInverse ETF Flow - thelegaladvocate.com

May 27, 2026

May 27, 2026

Ernexa Therapeutics advances ERNA-101 toward Q3 IND filing - Investing.com

May 27, 2026

May 27, 2026

Ernexa Therapeutics advances ERNA-101 toward Q3 IND filing By Investing.com - Investing.com Australia

May 27, 2026

May 27, 2026

Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development - The Globe and Mail

May 27, 2026

May 27, 2026

Ernexa Therapeutics (ERNA) Slides 2.5% as Weakness Persists Near Support LevelsTriple EMA - newsline.com

May 27, 2026

May 27, 2026

Ernexa stock is jumping today: What's going on? - MSN

May 27, 2026

May 25, 2026

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models - bioinformant.com

May 25, 2026

May 23, 2026

Ernexa Therapeutics (ERNA) Q3 2023 Earnings: Net loss of $1.03 per share highlights ongoing clinical investment; stock declines 3.77%Annual Report - newsline.com

May 23, 2026

May 23, 2026

Ernexa Therapeutics Inc. (ERNA) Q3 2023 Earnings: Narrowing Losses Amidst Pipeline ProgressProfit Announcement - The Legal Advocate

May 23, 2026

May 23, 2026

Ernexa Therapeutics (ERNA) Q3 2023 Earnings: Deepening Losses and Clinical-Phase Uncertainty Weigh on SharesPro Level Trade Signals - Newser

May 23, 2026

May 22, 2026

Ernexa Therapeutics Q3 2023 Earnings: Losses Deepen as Stock Declines, No Revenue ReportedGuidance Revision Trend - Newser

May 22, 2026

May 22, 2026

Ernexa Therapeutics (ERNA) Slips 3.8% as Shares Test Key Support Near $11.39SMA Signal - The Legal Advocate

May 22, 2026

May 20, 2026

Clear Street exits ownership reporting for Ernexa Therapeutics (NASDAQ: ERNA) - Stock Titan

May 20, 2026

May 20, 2026

ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know - sharewise.com

May 20, 2026

May 20, 2026

Ernexa Therapeutics Releases Virtual Investor KOL Connect - GlobeNewswire

May 20, 2026

May 18, 2026

ernexa therapeutics inc. Earnings dates - RTTNews

May 18, 2026

May 15, 2026

Ernexa Therapeutics (ERNA): Trustees report 66,751 shares, 5.6% stake - Stock Titan

May 15, 2026

May 15, 2026

ERNA stock almost doubled in value today – smashing rally leads to 7 trading halts - MSN

May 15, 2026

May 15, 2026

Ernexa Therapeutics Inc (ERNA) Stock Price, Quote, News & History - Benzinga

May 15, 2026

May 15, 2026

Ernexa Therapeutics (ERNA) 10K Form and Latest SEC Filings 2026 - MarketBeat

May 15, 2026

May 15, 2026

ERNA | Ernexa Therapeutics Inc. Common Analyst Forecasts - Quiver Quantitative

May 15, 2026

May 14, 2026

Bleichroeder LP discloses 6.86% stake in Ernexa Therapeutics (ERNA) - Stock Titan

May 14, 2026

May 14, 2026

Clear Street LLC reports 12.8% stake in Ernexa (NASDAQ: ERNA) - Stock Titan

May 14, 2026

May 13, 2026

Ernexa Therapeutics (ERNA) amendment: 118,342 shared holdings; 48,000 warrants noted - Stock Titan

May 13, 2026

May 13, 2026

Ernexa Stock Is Jumping Today: What's Going On? - Sahm

May 13, 2026

May 13, 2026

Nasdaq Dips Over 1%; US Inflation Surges To 3.8% In April - Sahm

May 13, 2026

May 12, 2026

Ernexa Therapeutics (ERNA) Stock Soars 78% Following Q1 Earnings and Pipeline Update - MEXC

May 12, 2026